Title:
ST2L ANTAGONISTS AND METHODS OF USE
Document Type and Number:
WIPO Patent Application WO/2013/165894
Kind Code:
A3
Abstract:
The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
More Like This:
Inventors:
DUFFY KAREN (US)
HEALY CATHERINE (US)
LAMB ROBERTA (US)
MALAVIYA RAVI (US)
PRATTA MICHAEL (US)
FURSOV NATALIE (US)
LUO JINQUAN (US)
NASO MICHAEL (US)
TORNETTA MARK (US)
WHEELER JOHN (US)
WU SHENG-JIUN (US)
HALL LEROY (US)
HEALY CATHERINE (US)
LAMB ROBERTA (US)
MALAVIYA RAVI (US)
PRATTA MICHAEL (US)
FURSOV NATALIE (US)
LUO JINQUAN (US)
NASO MICHAEL (US)
TORNETTA MARK (US)
WHEELER JOHN (US)
WU SHENG-JIUN (US)
HALL LEROY (US)
Application Number:
PCT/US2013/038637
Publication Date:
March 27, 2014
Filing Date:
April 29, 2013
Export Citation:
Assignee:
JANSSEN BIOTECH INC (US)
International Classes:
C07K16/24; A61K39/395
Domestic Patent References:
| WO2001021641A1 | 2001-03-29 | |||
| WO2008022295A2 | 2008-02-21 | |||
| WO2006055347A2 | 2006-05-26 | |||
| WO2000069914A2 | 2000-11-23 | |||
| WO2010080833A1 | 2010-07-15 |
Foreign References:
| US20030190311A1 | 2003-10-09 | |||
| US20100260770A1 | 2010-10-14 |
Other References:
LINGEL, A ET AL.: "Structure Of IL-33 and Its Interaction With The ST2 And IL-1 RAcP Receptors - Insight Into Heterotrimeric IL-1 Signaling Complexes.", STRUCTURE, vol. 17, 14 October 2009 (2009-10-14), pages 1398 - 1410, XP026932729
Attorney, Agent or Firm:
JOHNSON, Philip S. et al. (One Johnson & Johnson PlazaNew Brunswick, New Jersey, US)
Download PDF:
Previous Patent: CATHETER WITH DISTAL DIFFUSER
Next Patent: REFRIGERATION SYSTEM WITH PURGE USING ENRIVONMENTALLY-SUITABLE CHILLER REFRIGERANT
Next Patent: REFRIGERATION SYSTEM WITH PURGE USING ENRIVONMENTALLY-SUITABLE CHILLER REFRIGERANT